Xizang Weixinkang Pharmaceutical Co (SHSE:603676) YoY EBITDA Growth : -9.72% (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Xizang Weixinkang Pharmaceutical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Xizang Weixinkang Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -9.72%.

Xizang Weixinkang Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.22.

Xizang Weixinkang Pharmaceutical Co YoY EBITDA Growth Historical Data

The historical data trend for Xizang Weixinkang Pharmaceutical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xizang Weixinkang Pharmaceutical Co YoY EBITDA Growth Chart

Xizang Weixinkang Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

9.58

94.54

45.51

19.50

23.26

Xizang Weixinkang Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															59.35	3.55	8.06	350.00	-9.72

Xizang Weixinkang Pharmaceutical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Xizang Weixinkang Pharmaceutical Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(0.763	-	0.619)	/	\| 0.619 \|
=	23.26 %

Xizang Weixinkang Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(0.223	-	0.247)	/	\| 0.247 \|
=	-9.72 %

Xizang Weixinkang Pharmaceutical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Xizang Weixinkang Pharmaceutical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Xizang Weixinkang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Xizang Weixinkang Pharmaceutical Co Ltd (SHSE:603676) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

Yuanqu South Road, 3rd Floor, Building 4, Industrial Center, No. 5, Zone B, Lhasa Economic and Technological, Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000

Website

https://www.wxkpharma.com

Xizang Weixinkang Pharmaceutical Co Ltd is engaged in research & development, production and sales of chemical pharmaceutical preparations and their raw materials. It also produces and sells liver protection drugs and antibiotic products.

Executives

Weng Zi Zhong	senior management
Chen Shi Gong	Directors, senior managers
Zhou Xiao Bing	senior management
Liu Feng	Directors, senior managers
Yu Hai Bo	senior management
Zhang Hong	Directors, senior managers
Zheng Yan Xia	senior management
Wen Xiao Quan	Director

Xizang Weixinkang Pharmaceutical Co Headlines

No Headlines